Saghmos Therapeutics Announces Collaboration with Duke Clinical Research Institute to Optimize Phase 3 Cardio-Renal Metabolic Study
DCRI is the world’s largest academic clinical research organization and a pioneer in cardiovascular clinical research, combining clinical an
ACC 2024: DCRI faculty share cardiovascular expertise as part of more than 100 sessions over three days
APRIL 15, 2024 — Faculty experts from the Duke Clinical Research Institute (DCRI) shared insights and expertise on the latest cardiology research as part of more than 100 late-breaking
EMPACT-MI: Therapy Shows Promise in Delaying Hospitalizations for Heart Failure
About 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. There are limited treatments to prevent or slow that development.
Fortified Eggs Did Not Raise Cholesterol in Modest-Sized Cardiology Study
There are often conflicting headlines about whether certain foods are good or bad for you, and the news about eggs has been especially confusing. Search the topic online and you’ll find a wealth of articles spanning back decades.
Scale That Measures Fluid Retention Improves Prediction of Heart Failure Events
DCRI News from Technology and Heart Failure Therapeutics 2024
International Partnership Formed to Fight Antibacterial Resistance
The Antibacterial Resistance Leadership Group (ARLG), the European Clinical Research Alliance on Infectious Diseases (Ecraid), and ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network have joined forces to create a global alliance against antibacterial resistance.
Duke Centennial Spotlight: Dr. Robert Califf
An internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality, and clinical research, Dr. Robert Califf now heads the U.S. Food and Drug Administration.
V-INCLUSION Clinical Trial Will Soon Open for Enrollment
A new clinical trial led by the Duke Clinical Research Institute (DCRI) aims to understand whether a cholesterol-lowering medication can help control LDL-C (i.e. “bad cholesterol”) in real-world settings, specifically in diverse populations. Historically, cardiovascular clinical trials have not reflected the full diversity of the U.S. population, nor the people most affected by the conditions being studied.
DCRI Pilots ‘Food is Medicine: Makin’ Healthy Groceries’ Study in New Orleans
Healthy food is critical to good health, but accessing and preparing nutritious food often feels complicated. A new pilot study in New Orleans funded by the American Heart Association’s Health Care by Food initiative will test out new approaches.
Lessons from COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank
A recent publication in the journal Clinical Infectious Diseases highlights key takeaways from a DCRI Think Tank centered on the insights gained from the COVID-19 pandemic and 10 key steps on how this acquired knowledge can help inform the next pandemic response.